Close Menu

NEW YORK (GenomeWeb) – Pillar Biosciences said on Thursday that Columbia University Medical Center has received conditional approval from the New York State Department of Health for clinical use of a next-generation sequencing panel.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.